The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Fructose and the Metabolic Syndrome: Pathophysiology and Molecular Mechanisms
Abstract
Emerging evidence suggests that increased dietary consumption of fructose in Western society may be a potentially important factor in the growing rates of obesity and the metabolic syndrome. This review will discuss fructose-induced perturbations in cell signaling and inflammatory cascades in insulin-sensitive tissues. In particular, the roles of cellular signaling molecules including nuclear factor kappa B (NFkB), tumor necrosis factor alpha (TNF-alpha), c-Jun amino terminal kinase 1 (JNK-1), protein tyrosine phosphatase 1B (PTP-1B), phosphatase and tensin homolog deleted on chromosome ten (PTEN), liver X receptor (LXR), farnesoid X receptor (FXR), and sterol regulatory element-binding protein-1c (SREBP-1c) will be addressed. Considering the prevalence and seriousness of the metabolic syndrome, further research on the underlying molecular mechanisms and preventative and curative strategies is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
IKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Klaman, L. D., Boss, O., Peroni, O. D., Kim, J. K., Martino, J. L., Zabolotny, J. M., Moghal, N., Lubkin, M., Kim, Y.-B., Sharpe, A. H., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5479-5489.2000 · Cited by 1,235
Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
Virkamäki, A., Ueki, K., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6609 · Cited by 854
Havel, P. J. (2005) · Nutrition Reviews · doi:10.1111/j.1753-4887.2005.tb00132.x · Cited by 607
Stiles, B., Wang, Y., Stahl, A., Bassilian, S., Lee, W. P., Kim, Y.-J., Sherwin, R., Devaskar, S., Lesche, R., Magnuson, M. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308617100 · Cited by 436
Bandyopadhyay, G. K., Yu, J. G., Ofrecio, J., & Olefsky, J. M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2351 · Cited by 210
Research works printed but not linked: 61
- Amos, 1997, The rising global burden of diabetes and its complications: estimates and projections to the year 2010, Diabet Med, 14, S1
- Ludwig, 2004, Programming obesity in childhood, Lancet, 364, S226, 10.1016/S0140-6736(04)16688-9 · DOI
- Jurgens, 2005, Consuming fructose-sweetened beverages increases body adiposity in mice, Obes Res, 13, S1146, 10.1038/oby.2005.136 · DOI · Paper page
- Basciano, 2005, Fructose, insulin resistance, and metabolic dyslipidemia, Nutr Metab (Lond), 2, S5, 10.1186/1743-7075-2-5 · DOI · Paper page
- Nagata, 2004, Single nucleo-tide polymorphism (-468 Gly to A) at the promoter region of SREBP-1c associates with genetic defect of fructose-induced hepatic lipogenesis [corrected], J Biol Chem, 279, S29031, 10.1074/jbc.M309449200 · DOI
- Le, 2006, Metabolic effects of fructose, Curr Opin Clin Nutr Metab Care, 9, S469, 10.1097/01.mco.0000232910.61612.4d · DOI · Paper page
- Hansen, 2006, Is all fat the same? The role of fat in the pathogenesis of the metabolic syndrome and type 2 diabetes mellitus, Surgery, 139, S711, 10.1016/j.surg.2005.10.018 · DOI
- Reynisdottir, 1997, Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue, J Clin Endocrinol Metab, 82, S4162
- Kahn, 1992, Alterations in glucose transporter expression and function in diabetes: mechanisms for insulin resistance, J Cell Biochem, 48, S122, 10.1002/jcb.240480203 · DOI
- Fried, 1998, Omental and subcutaneous adipose tissues of obese subjects release interleukin-6:depot difference and regulation by glucocorticoid, J Clin Endocrinol Metab, 83, S847
- Hotamisligil, 1996, IRS-1 -mediated inhibition of insulin receptor tyrosine kinase activity in TNF-al-pha- and obesity-induced insulin resistance, Science, 271, S665, 10.1126/science.271.5249.665 · DOI · Paper page
- Kerouz, 1997, Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse, J Clin Invest, 100, S3164, 10.1172/JCI119872 · DOI · Paper page
- Shimomura, 2000, Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice, Mol Cell, 6, S77, 10.1016/S1097-2765(05)00010-9 · doi:10.1016/s1097-2765(05)00010-9 · Paper page
- Taghibiglou, 2002, Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of pro-tein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance, J Biol Chem, 277, S793, 10.1074/jbc.M106737200 · DOI · Paper page
- Wei, 2004, Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance, Am J Physiol Endocrinol Metab, 287, SE926, 10.1152/ajpendo.00185.2004 · DOI
- Czech, 1999, Signaling mechanisms that regulate glucose transport, J Biol Chem, 274, S1865, 10.1074/jbc.274.4.1865 · DOI · Paper page
- Wolfrum, 2004, Foxa2 regulates lipid metabolism and ketogen-esis in the liver during fasting and in diabetes, Nature, 432, S1027, 10.1038/nature03047 · DOI · Paper page
- Wolfrum, 2006, Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion, Cell Metab, 3, S99, 10.1016/j.cmet.2006.01.001 · DOI · Paper page
- Goodyear, 1995, Insulin receptor phosphoryla-tion, insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects, J Clin Invest, 95, S2195, 10.1172/JCI117909 · DOI · Paper page
- Goldstein, 1992, Protein-tyrosine phosphatases and the regulation of insulin action, J Cell Biochem, 48, S33, 10.1002/jcb.240480107 · DOI
- Qiu, 2004, Hepatic PTP-1B expression regulates the assembly and secretion of apolipoprotein B-containing lipoproteins: evidence from protein tyrosine phosphatase-1 B overexpression, knockout, and RNAi studies, Diabetes, 53, S3057, 10.2337/diabetes.53.12.3057 · DOI
- Sasaoka, 2006, Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity, Pharmacol Ther, 112, S799, 10.1016/j.pharmthera.2006.06.001 · DOI
- Clement, 2001, The lipid phosphatase SHIP2 controls insulin sensitivity, Nature, 409, S92, 10.1038/35051094 · DOI · Paper page
- Fukui, 2005, Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5′-phosphatase 2) on insulin signaling and glucose metabolism in mice, Diabetes, 54, S1958, 10.2337/diabetes.54.7.1958 · DOI
- Carlson, 2003, Enhanced basal activation of mito-gen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the down-regulation of GLUT4 expression, Diabetes, 52, S634, 10.2337/diabetes.52.3.634 · DOI · Paper page
- Tsai, 2007, MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells. Potential role of ERK in VLDL-ApoB100 particle assembly, Arterioscler Thromb Vasc Biol, 27, S211, 10.1161/01.ATV.0000249861.80471.96 · DOI
- Allister, 2005, Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes, Diabetes, 54, S1676, 10.2337/diabetes.54.6.1676 · DOI
- Corbould, 2006, Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome, Diabetes, 55, S751, 10.2337/diabetes.55.03.06.db05-0453 · DOI · Paper page
- Lazar, 2006, The humoral side of insulin resistance, Nat Med, 12, S43, 10.1038/nm0106-43 · DOI
- Li, 2003, Innate immunity in the liver, Curr Opin Gastroenterol, 19, S565, 10.1097/00001574-200311000-00009 · DOI
- Choi, 2005, Role of inflammation in nonalcoholic steatohepatitis, Curr Opin Gastroenterol, 21, S702, 10.1097/01.mog.0000182863.96421.47 · DOI
- Davis, 2000, Signal transduction by the JNK group of MAP kinases, Cell, 103, S239, 10.1016/S0092-8674(00)00116-1 · DOI · Paper page
- Nakatani, 2004, Modulation of the JNK pathway in liver affects insulin resistance status, J Biol Chem, 279, S45803, 10.1074/jbc.M406963200 · DOI · Paper page
- Kelley, 2004, High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation, Endocrinology, 145, S548, 10.1210/en.2003-1167 · DOI · Paper page
- Wei, 2005, Fructose selectively modulates c-jun N-terminal kinase activity and insulin signaling in rat primary hepatocytes, J Nutr, 135, S1642, 10.1093/jn/135.7.1642 · DOI
- Taghibiglou, 2000, Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellu-lar ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model, J Biol Chem, 275, S8416, 10.1074/jbc.275.12.8416 · DOI · Paper page
- Kim, 2006, NF-kappaB and IKK as therapeutic targets in cancer, Cell Death Differ, 13, S738, 10.1038/sj.cdd.4401877 · DOI · Paper page
- Boden, 2005, Free fatty acids produce insulin resistance and activate the proin-flammatory nuclear factor-kappaB pathway in rat liver, Diabetes, 54, S3458, 10.2337/diabetes.54.12.3458 · DOI · Paper page
- Janabi, 2000, Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients, Arterioscler Thromb Vasc Biol, 20, S1953, 10.1161/01.ATV.20.8.1953 · DOI · Paper page
- Rohl, 2004, Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance, J Clin Invest, 113, S474, 10.1172/JCI200418712 · DOI
- Chung, 2005, Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-de-pendent cytokine production, J Biol Chem, 280, S38445, 10.1074/jbc.M508159200 · DOI · Paper page
- Gao, 2003, Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases, J Biol Chem, 278, S24944, 10.1074/jbc.M300423200 · DOI · Paper page
- Dietze, 2004, Inhibitor kappaB kinase is involved in the paracrine crosstalk between human fat and muscle cells, Int J Obes Relat Metab Disord, 28, S985, 10.1038/sj.ijo.0802701 · DOI
- Sell, 2006, Pathways leading to muscle insulin resistance. The muscle-fat connection, Arch Physiol Biochem, 112, S105, 10.1080/13813450600711540 · DOI · Paper page
- Kalaany, 2006, LXRS and FXR: the yin and yang of cholesterol and fat metabolism, Annu Rev Physiol, 68, S159, 10.1146/annurev.physiol.68.033104.152158 · DOI · Paper page
- Tobin, 2002, Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis, J Biol Chem, 277, S10691, 10.1074/jbc.M109771200 · DOI · Paper page
- Cagen, 2005, Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements, Biochem J, 385, S207, 10.1042/BJ20040162 · DOI
- Sinal, 2000, Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid ho-meostasis, Cell, 102, S731, 10.1016/S0092-8674(00)00062-3 · DOI · Paper page
- Zhang, 2006, Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice, Proc Natl Acad Sci USA, 103, S1006, 10.1073/pnas.0506982103 · DOI · Paper page
- Cariou, 2006, The expanding role of the bile acid receptor FXR in the small intestine, J Hepatol, 44, S1213, 10.1016/j.jhep.2006.03.006 · DOI
- Watanabe, 2004, Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c, J Clin Invest, 113, S1408, 10.1172/JCI21025 · DOI · Paper page
- Hirokane, 2004, Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4, J Biol Chem, 279, S45685, 10.1074/jbc.M404255200 · DOI · Paper page
- Bilz, 2006, Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipid-emic hamsters, Am J Physiol Endocrinol Metab, 290, SE716, 10.1152/ajpendo.00355.2005 · DOI
- Yamashita, 2001, A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver, Proc Natl Acad Sci USA, 98, S9116, 10.1073/pnas.161284298 · DOI · Paper page
- Dentin, 2006, Hepatic gene regulation by glucose and polyunsaturated fatty acids: a role for ChREBP, J Nutr, 136, S1145, 10.1093/jn/136.5.1145 · DOI
- Federico, 2006, Intestinal insulin resistance and aberrant production of apoli-poprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phospha-tase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine, Diabetes, 55, S1316, 10.2337/db04-1084 · DOI
- Dentin, 2005, Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c):two key regulators of glucose metabolism and lipid synthesis in liver, Biochimie, 87, S81, 10.1016/j.biochi.2004.11.008 · DOI · Paper page
- Zoltowska, 2001, Circulating lipoproteins and hepatic sterol metabolism in Psam-momys obesus prone to obesity, hyperglycemia and hyperinsulinemia, Atherosclerosis, 157, S85, 10.1016/S0021-9150(00)00711-5 · DOI
- Sullivan, 1993, The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia, Lab Anim Sci, 43, S575
- Nistor, 1987, The hyperlipid-emic hamster as a model of experimental atherosclerosis, Atherosclerosis, 68, S159, 10.1016/0021-9150(87)90106-7 · DOI · Paper page
- Carpentier, 2002, Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster, J Biol Chem, 277, S28795, 10.1074/jbc.M204568200 · DOI
Cited by
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Johnson, R. K., Appel, L. J., Brands, M., Howard, B. V., Lefevre, M., Lustig, R. H., Sacks, F., Steffen, L. M., & Wylie-Rosett, J. (2009) · Circulation · doi:10.1161/circulationaha.109.192627 · Cited by 1,207
Vitart, V., Rudan, I., Hayward, C., Gray, N. K., Floyd, J., Palmer, C. N., Knott, S. A., Kolcic, I., Polasek, O., Graessler, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.106 · Cited by 799
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771
Regulation of the fructose transporter GLUT5 in health and disease
Douard, V., & Ferraris, R. P. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90245.2008 · Cited by 474
Metadata
- Authors
- Rutledge, A. C., & Adeli, K.
- Venue
- Nutrition Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06-28
- Volume
- 65
- Issue
- 6 Pt 2
- Pages
- S13-S23
- ISSN
- 0029-6643 (ISSN-L)
- OpenAlex
- W2150126813
- Cited by
- 240
- References
- 11
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fructose and the Metabolic Syndrome: Pathophysiology and Molecular Mechanisms. https://app.cochat.ai/papers/10.1111/j.1753-4887.2007.tb00322.x
- The paper
- Rutledge, A. C., & Adeli, K. (2008). Fructose and the Metabolic Syndrome: Pathophysiology and Molecular Mechanisms. Nutrition Reviews. https://doi.org/10.1111/j.1753-4887.2007.tb00322.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.